01 11AstraZeneca Canada Inc.
01 32262647
02 32277112
03 22356706
04 12560874
05 12560981
06 12619426
01 5EXENATIDE
02 6Exenatide
01 5POWDER FOR SUSPENSION
02 3Solution for injection in 1.2 mL pre-filled pens
03 3Solution for injection in 2.4 mL pre-filled pens
01 32017-08-08
02 32018-01-07
03 22020-01-14
04 12024-04-15
05 12025-04-15
06 12026-08-18
Patent Expiration Date : 2018-01-07
Date Granted : 2008-08-26
Brand Name : BYETTA
Patent Number : 2277112
Filing Date : 1998-01-07
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 1.2 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2018-01-07
Date Granted : 2008-08-26
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
Brand Name : BYETTA
Patent Number : 2262647
Filing Date : 1997-08-08
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 1.2 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
Patent Expiration Date : 2018-01-07
Date Granted : 2008-08-26
Brand Name : BYETTA
Patent Number : 2277112
Filing Date : 1998-01-07
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 2.4 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2018-01-07
Date Granted : 2008-08-26
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
Brand Name : BYETTA
Patent Number : 2262647
Filing Date : 1997-08-08
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 2.4 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
Patent Expiration Date : 2020-01-14
Date Granted : 2014-09-30
Brand Name : BYETTA
Patent Number : 2356706
Filing Date : 2000-01-14
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 1.2 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2020-01-14
Date Granted : 2014-09-30
Patent Expiration Date : 2020-01-14
Date Granted : 2014-09-30
Brand Name : BYETTA
Patent Number : 2356706
Filing Date : 2000-01-14
Strength per Unit : 250 ?g / mL
Dosage Form : Solution for injection in 2.4 mL pre-filled pens
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2020-01-14
Date Granted : 2014-09-30
Patent Expiration Date : 2026-08-18
Date Granted : 2016-06-21
Brand Name : BYDUREON
Patent Number : 2619426
Filing Date : 2006-08-18
Strength per Unit : 2 mg / dose
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-08-18
Date Granted : 2016-06-21
Patent Expiration Date : 2025-04-15
Date Granted : 2013-02-19
Brand Name : BYDUREON
Patent Number : 2560874
Filing Date : 2005-04-15
Strength per Unit : 2 mg / dose
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-15
Date Granted : 2013-02-19
Patent Expiration Date : 2024-04-15
Date Granted : 2013-02-19
Brand Name : BYDUREON
Patent Number : 2560981
Filing Date : 2004-04-15
Strength per Unit : 2 mg / dose
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-04-15
Date Granted : 2013-02-19
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
Brand Name : BYDUREON
Patent Number : 2262647
Filing Date : 1997-08-08
Strength per Unit : 2 mg / dose
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-08-08
Date Granted : 2007-12-04
LOOKING FOR A SUPPLIER?
